Cited by 394Computational Drug Discovery MethodsSynthesis and Characterization of Heterocyclic CompoundsChemical Synthesis and Analysis

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Chemical substructures that enrich for biological activity

Open access
Klekota, Justin, Roth, Frederick P.·2008·Bioinformatics

Abstract

Motivation: Certain chemical substructures are present in many drugs. This has led to the claim of ‘privileged’ substructures which are predisposed to bioactivity. Because bias in screening library construction could explain this phenomenon, the existence of privilege has been controversial. Results: Using diverse phenotypic assays, we defined bioactivity for multiple compound libraries. Many substructures were associated with bioactivity even after accounting for substructure prevalence in the library, thus validating the privileged substructure concept. Determinations of privilege were confirmed in independent assays and libraries. Our analysis also revealed ‘underprivileged’ substructures and ‘conditional privilege’—rules relating combinations of substructure to bioactivity. Most previously reported substructures have been flat aromatic ring systems. Although we validated such substructures, we also identified three-dimensional privileged substructures. Most privileged substructures display a wide variety of substituents suggesting an entropic mechanism of privilege. Compounds containing privileged substructures had a doubled rate of bioactivity, suggesting practical consequences for pharmaceutical discovery. Contact: fritz_roth@hms.harvard.edu Supplementary information: Supplementary data are available at Bioinformatics online.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bioinformatics/btn479

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 62 references

2 of the 62 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Patchett, 2000, Privileged structures – an update, Annu. Rep. Med. Chem, 35, 289

Cited by

Sorted by citations

Items 301–394 of 394

Metadata

Authors
Klekota, J., & Roth, F. P.
Affiliations
Harvard University (US)
Corresponding author
Roth, Frederick P.
Venue
Bioinformatics
Published
2008-09-11
Volume
24
Issue
21
Pages
2518-2525
ISSN
  • 1367-4803 (ISSN-L)
  • 1367-4811
OpenAlex
W2107081909
Cited by
392
References
62
Citations by year
2026: 27 · 2025: 28 · 2024: 43 · 2023: 37 · 2022: 24 · 2021: 22 · 2020: 22 · 2019: 18 · 2018: 34 · 2017: 27 · 2016: 31 · 2015: 22 · 2014: 17 · 2013: 13 · 2012: 14
FWCI
5.66
Type
journal article
Language
en
Open access
Locations
  • Bioinformatics (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • Centre National de la Recherche Scientifique
  • National Institute on Aging (R01AG017115)
  • National Heart, Lung, and Blood Institute (U01HL081341)
  • National Human Genome Research Institute (R01 HG0017115, R01HG003224, P50HG004233)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords
chemical substructures, bioactivity prediction, chemical libraries, phenotypic assays, aromatic ring systems, drug discovery, structure-activity relationship
MeSH terms
Animals, Cells, Cultured, Pharmaceutical Preparations, Humans, Ligands, Structure-Activity Relationship, Drug Design, Databases, Factual, Combinatorial Chemistry Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review